This short course introduces general practitioners to the basic concepts of addiction medicine in Australia, i.e., the epidemiology of substance misuse, the effects of common substance misuse the opioid crisis, and the principles of pharmacotherapy.

As you are well aware, COVID-19 has affected the world in ways not seen in recent history.
It is important to understand how we as a society have coped and also how we as clinicians have had to adapt our treatment models to help our vulnerable patients

This video is provided by Meducate to help you understand the basic principles that underly the management of alcohol use disorder and tobacco use disorder.

Long-acting Injectable Buprenorphine (LAIB) is a formulation of buprenorphine pharmacotherapy that has the promise to be a true game-changer in the area of Medication-Assisted Treatment of Opioid Dependence.

Opioid stewardship in the context of pain management – presented by Dr Ann Saunders
Alcohol use disorder – assessment diagnosis and management – presented by Dr Thileepan Naren
Methamphetamine use disorder – assessment diagnosis and management – presented by Dr Ferghal Armstrong
Transtheoretical model of change: motivational interviewing and cbt techniques to achieve abstinence – presented by Ms Marie Eisma

Clinical boundaries – presented by Dr Ferghal Armstrong

 

High Risk GP Prescribing – presented by Dr Anne Saunders

 

Transfers - From high dose opioids to pharmacotherapy – presented by Dr Thileepan Naren